RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the industry-leading Metasite, announced today that it has acquired the life sciences platform from ...
RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the clinical research industry-leading Metasite™, has been named the winner of the prestigious "Best ...
New release sets the bar as the most comprehensive platform to orchestrate decentralized study conduct—unifying stakeholder journeys, increasing compliance, and generating the highest-quality data for ...
Syneos Health has signed up with siteless trial specialist Science 37 to boost its decentralized clinical trial offerings. The deal, financials of which were not made public, will see the companies ...
37 Medical Director Christopher Reist using the company’s platform. Playa Vista-based Science 37 Inc., a digital clinical trial firm, is becoming a publicly listed company through a merger with ...
PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clinical trials, announced today the completion of a Phase 2b study for AOBiome, a clinical-stage life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback